Picture of Prostatype Genomics AB logo

PROGEN Prostatype Genomics AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Prostatype Genomics Acquires Clia Certificate

Feb 8 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * ACQUIRES CLIA CERTIFICATE TO FACILITATE RAPID US MARKET
LAUNCH
WITH A SIGNIFICANTLY STRONGER FINANCIAL OUTLOOK
    * BY HOLDING A CLIA CERTIFICATE, PROSTATYPE GENOMICS INC.
WILL BE
ABLE TO ACCEPT REIMBURSEMENT PAYMENTS FROM MEDICARE AND
COMMERCIAL PAYERS AND THEN UTILIZE ITS CLIA LABORATORY FOR
ANALYZING TESTS

Source text for Eikon:  ID:nWkr4RvYhF 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Prostatype Genomics AB

See all news